Geratherm Medical AG (LON: 0EL9)

Geratherm Medical AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4.24	5.24	8.74	2.26	4.85	4.14
Short-Term Investments	2.09	2.51	2.15	4.21	5.41	5.4
Cash & Short-Term Investments	6.33	7.74	10.89	6.47	10.26	9.54
Cash Growth	-41.90%	-28.85%	68.25%	-36.95%	7.54%	21.99%
Accounts Receivable	2.8	1.81	3.78	3.18	3.21	2.51
Other Receivables	-	-	-	1.05	0.25	0.53
Receivables	2.8	1.81	3.78	4.23	3.46	3.03
Inventory	8.52	9.36	7.03	8.54	7.31	7.86
Other Current Assets	1.52	1.97	1.63	0.38	0.38	0.35
Total Current Assets	19.16	20.88	23.32	19.61	21.4	20.79
Property, Plant & Equipment	8.9	9.45	9.99	9.32	9.68	8.63
Long-Term Investments	0.63	0.63	0.63	1.37	1.72	1.52
Goodwill	0.07	0.07	0.08	0.09	0	0
Other Intangible Assets	4.72	4.56	4.04	1.07	0.3	0.24
Long-Term Deferred Charges	-	-	-	2.99	2.78	1.95
Other Long-Term Assets	0.18	0.13	0.33	0.1	0.12	0.13
Total Assets	33.65	35.72	38.38	34.56	35.99	33.26
Accounts Payable	0.74	0.85	1.51	1.43	1.5	1.41
Accrued Expenses	-	2.46	2.45	1.68	1.49	1.6
Current Portion of Long-Term Debt	-	3.24	-	2.84	3.2	2.06
Current Portion of Leases	-	-	-	0.28	0.25	0.29
Current Income Taxes Payable	0.13	0.06	0.14	0.05	0.08	0.04
Current Unearned Revenue	-	-	-	1.76	0.89	1.27
Other Current Liabilities	-	0.51	0.22	0.39	0.41	0.36
Total Current Liabilities	0.87	7.12	4.31	8.43	7.83	7.02
Long-Term Debt	6.57	3.99	9.29	5.95	6.62	5.62
Long-Term Leases	-	-	-	0.25	0.33	0.06
Long-Term Unearned Revenue	1.35	1.43	1.52	1.29	1.23	1.35
Long-Term Deferred Tax Liabilities	0.07	0.03	0.03	0.01	0.05	0.03
Other Long-Term Liabilities	3.42	0.54	1	-	-	-
Total Liabilities	12.29	13.11	16.15	15.93	16.07	14.08
Common Stock	5.41	5.41	5.44	4.95	4.95	4.95
Retained Earnings	-1.6	-0.37	-0.66	-0.64	1.27	0.46
Comprehensive Income & Other	17.36	17.29	17.56	14.21	14.08	14.42
Total Common Equity	21.17	22.33	22.34	18.52	20.3	19.83
Minority Interest	0.2	0.28	-0.11	0.11	-0.38	-0.65
Shareholders' Equity	21.37	22.61	22.23	18.63	19.93	19.18
Total Liabilities & Equity	33.65	35.72	38.38	34.56	35.99	33.26
Total Debt	6.57	7.23	9.29	9.32	10.4	8.03
Net Cash (Debt)	-0.24	0.51	1.59	-2.85	-0.14	1.51
Net Cash Growth	-	-67.71%	-	-	-	-62.49%
Net Cash Per Share	-0.05	0.09	0.29	-0.58	-0.03	0.31
Filing Date Shares Outstanding	5.38	5.38	5.44	4.95	4.95	4.95
Total Common Shares Outstanding	5.38	5.38	5.44	4.95	4.95	4.95
Working Capital	18.29	13.77	19	11.18	13.57	13.76
Book Value Per Share	3.94	4.15	4.10	3.74	4.10	4.01
Tangible Book Value	16.39	17.7	18.21	17.36	20.01	19.58
Tangible Book Value Per Share	3.05	3.29	3.35	3.51	4.04	3.96
Land	-	7.33	7.33	7.35	7.23	5.23
Machinery	-	14.36	14.44	13.27	12.86	12.33
Construction In Progress	-	0.03	0.84	0.31	0.37	1.32
Order Backlog	-	-	-	0.08	0.85	0.1

Source: S&P Capital IQ. Standard template. Financial Sources.